We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+3.92%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$392M
AUM Growth
+$13.4M
Cap. Flow
+$1.77M
Cap. Flow %
0.45%
Top 10 Hldgs %
64.87%
Holding
28
New
2
Increased
13
Reduced
8
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 89.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGX icon
26
Quest Diagnostics
DGX
$25.1B
-114,628
Closed -$8.81M
EW icon
27
Edwards Lifesciences
EW
$47.6B
-663,000
Closed -$15.7M
LPNT
28
DELISTED
LifePoint Health, Inc.
LPNT
-119,698
Closed -$8.79M

Similar funds

Sector Gamma AS's Q2 2015 Portfolio in Review

As of Q2 2015, Sector Gamma AS held 28 positions worth $392M, up 3.6% from $378M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sector Gamma AS's Q2 2015 filing shows 2 new, 13 increased, 8 reduced and 4 closed positions. Its largest new stake was Johnson & Johnson: 287,800 shares worth $28M. The largest sale was Edwards Lifesciences, an estimated $15.7M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 90% a quarter earlier.

  • Sector Gamma AS's largest Q2 2015 buy was Johnson & Johnson: 287,800 shares worth $28M.
  • Sector Gamma AS added most to Baxter International in Q2 2015, an estimated $4.95M increase.
  • Sector Gamma AS's biggest Q2 2015 reduction was Eli Lilly, cutting an estimated $7.03M.
  • Sector Gamma AS fully exited Edwards Lifesciences in Q2 2015, selling an estimated $15.7M.
  • Sector Gamma AS's ten largest holdings make up 65% of its $392M portfolio in Q2 2015.
  • Sector Gamma AS opened 2 new positions and closed 4 in Q2 2015.
  • Sector Gamma AS's portfolio value rose 3.6% quarter-over-quarter to $392M.

Based on Sector Gamma AS's 13F filing for Q2 2015, filed 13 Aug 2015.